Come up with a name for your new list and we'll add to it:
Modus Therapeutics raised a round of funding on July 13, 2018. Investors include
HealthCap Venture Capital.
Modus Therapeutics, fka Dilaforette, is a clinical-stage drug development company developing new pharmaceutical therapies to restore impaired blood flow and oxygen transport in rare diseases with larg…